Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.34 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.34 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.34 |
| ▸ | CYP2F1 | P24903 | 1/20 | 0.34 |
| ▸ | CYP2C18 | P33260 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1467139 | 0.84 | ALDH1A1 (0.46) | ALDH1A1CYP1A1CYP1B1CYP1A2CYP2E1 | |
| SCHEMBL636461 | 0.82 | SLC6A4 (0.46) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL162234 | 0.82 | SLC6A4 (0.46) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL2837925 | 0.82 | SLC6A4 (0.46) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL14687601 | 0.82 | TAAR1 (0.47) | ALDH1A1CYP3A4TAAR1SLC6A4SMN1; SMN2 | |
| SCHEMBL14687588 | 0.82 | TAAR1 (0.47) | ALDH1A1CYP3A4TAAR1SLC6A4SMN1; SMN2 | |
| SCHEMBL30664386 | 0.81 | SLC6A4 (0.44) | ALDH1A1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL1465845 | 0.77 | ALDH1A1 (0.38) | ALDH1A1TAAR1SLC6A4HTR2A | |
| SCHEMBL10038034 | 0.77 | ACHE (0.52) | ALDH1A1KMT2ASLC6A4SMN1; SMN2 | |
| SCHEMBL16329073 | 0.77 | ACHE (0.52) | ALDH1A1KMT2ASLC6A4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100311975-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2010-12-09 | — | — | US | claimed |
| EP-2215101-A1 | CATIONIC TRANSITION METAL CATALYSTS | Kanata Chemical Technologies Inc. (CA) | 2010-08-11 | — | — | EP | claimed |
| WO-2009055912-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2009-05-07 | — | — | WO | claimed |
| US-8518368-B2 | Method for the production of hydrogen from ammonia borane | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2013-08-27 | — | — | US | disclosed |
| US-20110070152-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2011-03-24 | — | — | US | disclosed |
| US-20100311975-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2010-12-09 | — | — | US | disclosed |
| EP-2215101-A1 | CATIONIC TRANSITION METAL CATALYSTS | Kanata Chemical Technologies Inc. (CA) | 2010-08-11 | — | — | EP | disclosed |
| EP-2158154-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | Kanata Chemical Technologies Inc. (CA) | 2010-03-03 | — | — | EP | disclosed |
| WO-2009055912-A1 | CATIONIC TRANSITION METAL CATALYSTS | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2009-05-07 | — | — | WO | disclosed |
| WO-2008141439-A1 | METHOD FOR THE PRODUCTION OF HYDROGEN FROM AMMONIA BORANE | KANATA CHEMICAL TECHNOLOGIES INC. (CA) | 2008-11-27 | — | — | WO | disclosed |
| US-6878838-B2 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2005-04-12 | — | — | US | disclosed |
| WO-2004084834-A2 | CHIRAL POROUS METAL PHOSPHONATES FOR HETEROGENEOUS ASYMMETRIC CATALYSIS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2004-10-07 | — | — | WO | disclosed |
| US-20040192543-A1 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | NORTH CAROLINA AT CHAPEL HILL, UNIVERSITY OF, THE | 2004-09-30 | — | — | US | disclosed |
| US-20030045727-A1 | Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-1254885-A1 | PROCESS FOR PREPARING OPTICALLY ACTIVE SECONDARY ALCOHOLS HAVING NITROGENOUS OR OXYGENIC FUNCTIONAL GROUPS | Asahi Kasei Kabushiki Kaisha (JP) | 2002-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045727-A1 | Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups | ADH1A, ADH5, ADH1C | ALDH1A1 85/4885CYP1A1 223/4885CYP1B1 130/4885 |
| US-20100311975-A1 | CATIONIC TRANSITION METAL CATALYSTS | AP2M1, OPRM1, CD81 | ALDH1A1 3759/4885CYP1A1 4357/4885CYP1B1 4032/4885 |
| US-20040192543-A1 | Chiral porous metal phosphonates for heterogeneous asymmetric catalysis | ZKSCAN2, TPRKB, KHK | ALDH1A1 4320/4885CYP1A1 3935/4885CYP1B1 3738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.